| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.004 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |